Page 46 - Forward Looking Statements News Today

News summary Fourth quarter revenue of $22.3 billion and full-year revenue of $88.4 billionFull-year operating income of $5.2 billion and non-GAAP operating income of $7.7 billionFull-year cash flow...

EnVVeno Medical Reports Fourth Quarter and Year-End 2023 Financial ...

Hayward Holdings, Inc. ("Hayward" or the "Company"), a global designer, manufacturer, and marketer of a broad portfolio of pool and outdoor living technology, today announced financial results for the fourth quarter and full fiscal year ended...

Operator: Good afternoon, and welcome to the Monster Beverage Company Fourth Quarter 2023 Conference Call. All participants will be in listen-only mode.

Operator: Good day and thank you for standing by. Welcome to the Cytek Biosciences Fourth Quarter 2023 Earnings Conference Call.

First patients in clinical study at Beilinson Hospital were scanned with the Nanox.ARC, a stationary X-ray system that produces 3D tomographic images Study may help determine clinical utility of...

Diversified Healthcare Trust (NASDAQ:DHC) Q4 2023 Earnings Call Transcript February 27, 2024 DHC isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome to the Diversified Healthcare Trust Fourth Quarter 2023 Earnings Conference Call. All participants will be […]

Q4total revenue year-over-year growth of16%to$150.6 million; fiscal year total revenue growth of17% to $560.6 millionARR year-over-year growth of 15% to $588.6 million as of December 31, 2023GAAP operating loss of

SOUTH SAN FRANCISCO, Calif., Feb. 28, 2024 -- Allogene Therapeutics, Inc. , a clinical-stage biotechnology company pioneering the development of allogeneic CAR T products for cancer and autoimmune...

VTEX beats earnings expectations. Reported EPS is $0.02, expectations were $0.01.